Periodic Reporting for period 4 - PHARMS (Bacteriophage inhibition of antibiotic-resistant pathogenic microbes and founding for novel therapeutic strategies)

Antimicrobial resistance (AMR) poses a major global threat, projected to cause more deaths than cancer, diabetes, and cardiovascular diseases by 2050 if no new therapies emerge. Only one new antibiotic class has reached the market in the past two decades, as traditional...